SCHEMBL4354242

SCHEMBL4354242

O=C1N=C(N2CCOCC2)S/C1=C/c1cccc(C(F)(F)F)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.63
MEN1 O00255 3/20 0.63
ALDH1A1 P00352 10/20 0.57
CYP1A2 P05177 2/20 0.57
CYP2C19 P33261 2/20 0.57
MAPT P10636 11/20 0.56
HTT P42858 2/20 0.56
RAB9A P51151 4/20 0.55
NPC1 O15118 2/20 0.55
SMN1; SMN2 Q16637 3/20 0.53
HCRTR1 O43613 1/20 0.53
KDM4E B2RXH2 1/20 0.52
GAA P10253 1/20 0.52
NPSR1 Q6W5P4 2/20 0.52
HPGD P15428 1/20 0.52
LMNA P02545 2/20 0.50
POLB P06746 2/20 0.50
CISD1 Q9NZ45 2/20 0.50
TTR P02766 1/20 0.50
PIM1 P11309 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4354246 1.00 KMT2A (0.63) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
Bromide SCHEMBL4356134 0.99 KMT2A (0.62) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
Bromide SCHEMBL4356131 0.99 KMT2A (0.62) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL4355055 0.88 ALDH1A1 (0.57) KMT2AMEN1ALDH1A1MAPTHTT
SCHEMBL4355053 0.88 ALDH1A1 (0.57) KMT2AMEN1ALDH1A1MAPTHTT
SCHEMBL4358705 0.86 MAPT (0.62) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL4358703 0.86 MAPT (0.62) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL4363345 0.83 ALDH1A1 (0.67) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL4363340 0.83 ALDH1A1 (0.67) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL4354253 0.82 ALDH1A1 (0.78) KMT2AMEN1ALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 KMT2A 3923/4885MEN1 1725/4885ALDH1A1 284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.